Skip to main content

Advertisement

Table 3 Demographic, clinical and thermographic characterization of the patients (N = 36); patients described in detail are marked in italics

From: High-resolution infrared thermography: a new tool to assess tungiasis-associated inflammation of the skin

Initial patient Sex Age Foot Number of viable/nonviable/manipulated lesions Stage of lesions Topographic localization of lesionsa,b Signs of acute inflammation (mSSAT) in the index areac Signs of chronic inflammation (mSSCT) of the index aread Pain (0–4) Temperature of the foot at day 0 (°C)e Perilesional temperature at day 0 (°C) of the index areae Perilesional temperature at day 4 (°C) of the index areae
BMR F 14 L 1/0/0 1 10 0.5 0.5 2 29.34 31.62
    R 1/0/0 1 2 0.5 0.5 2 30.40 31.41
RMR M 24 R 0/0/1 0 1 4.0 4.0. 2 27.46 28.38
OR M 16 L 1/0/0 3b 1 3.0 3.0 1 25.36 29.19
AMR F 17 R 1/0/0 3a 8 3.0 1.0 3 29.71 31.77
BLS M 13 R 1/0/0 3b 2 2.0 3.0 2 21.42 22.31
CER M 6 L 0/0/3 0 8/8/9 3.0 2.0 4 21.35 24.59
MMR F 20 L 1/0/0 3a 10 2.5 0.0 3 24.01 24.34
RJR M 15 L 1/0/0 2 11 1.0 1.0 0 22.47 24.83
DSS M 10 L 2/0/0 2,3a 7/8 2.0 1.0 2 26.23 27.26
SR F 13 R 1/0/0 3a 8 4.0 2.0. 3 26.52 29.58
RDS M 27 L 1/0/0 2 5 6.0 5.0 3 27.98 29.27
    R 1/0/0 3a 2 2.0 5.0 3 28.42 32.98
ENR M 18 L 1/0/0 3a 6 0.0 2.0 0 27.09 27.79
AGR F 12 L 0/1/0 4a 1 1.5 1.0 0 27.06 29.19
ELR F 8 R 1/1/0 2/4a 9/10 0.0 1.0 0 22.98 23.96
CMR F 19 R 0/0/2 0 1/6 0.0 4.0 0 27.49 29.33
TAR F 21 L 1/0/0 3a 2 0.0 5.0 0 27.67 28.77
    R 2/0/0 2 3 0.0 3.0 0 27.43 29.46
BDR F 23 L 0/2/0 4b 1 0.0 5.0 0 26.82 27.87
MGR F 5 L 2/0/0 1,3a 4 0.0 0.0 0 22.33 22.26
TMR F 17 L 1/0/0 2 11 2.0 0.0 3 21.66 21.84
DRJ F 16 L 2/0/0 3a,3b 3/11 1.0 0.0 0 27.18 27.29
MNR M 15 L 1/0/0 2 10 0.0 0.0 0 28.18 28.52
JNR F 20 L 1/0/0 3a 11 0.0 0.0 0 23.33 24.05
RNR M 55 L/R -   Whole foot 7.0 6.0 4 - -
BDR M 16 L 1/0/0 2 8 0.0 0.0 0 27.66 28.77
AAR F 11 L 1/0/0 3a 9 0.0 0.0 0 25.70 28.30
    R 1/00 3a 10 0.0 0.0 0 24.78 26.44
NMS M 23 L 2/0/0 2 1 2.0 4.02.5 2 27.79 30.52
    R 3/0/0 3a 5 6.0 4.0 3 27.41 30.45
JMR M 10 L 4/0/1 2,3a 3/4/8/ 5 4.0 5.0 2 32.57 33.42  
YAR F 12 L 4/0/0 3b,2 1 /2 3.0 3.0 1 30.29 31.03 17.10
MRR F 13 L 6/1/0 2,3a,3b/4b 6/7 /11 4.0 2.0. 4 25.90 28.10 24.30
ASB F 7 L 1/0/0 3b 6 4.0 1.0 2 28.26 30.67 20.91
ELR F 5 R 2/0/0 3a,3b 10/11 4.0 1.0 1 25.82 28.03 20.96
EBR M 6 R 6/0/0 2,3a,3b 6/7/12 4.0 2.0 1 27.93 30.87 28.42
AMR F 12 L 1/0/0 1 3 0.0 0.0 0 28.34 29.06 23.34
JNR M 7 L 1/0/0 1 3 2.0 1.0 0 29.41 30.00 18.10
EMR F 16 L 1/0/0 2 10 2.0 1.0 0 26.65 28.45 23.50
DR F 12 L 1/0/0 1 10 1.0 1.0 0 25.25 27.55 20.70
  1. aIf more than one area was affected, an index area was selected for thermographic evaluation (index area underlined)
  2. b(1) toe nail rim = 1, (2) toe nail rim = 2, (3) toe nail rim = 3, (4) toe nail rim = 4, (5) toe nail rim = 5, (1) toe sole = 6, (2) toe sole = 7, (3) toe sole = 8, (4) toe sole = 9, (5) toe sole = 10, foot sole = 11, heel = 12, medial foot rim = 13, lateral foot rim = 15
  3. cTaking into consideration the index lesion (presence of oedema, erythema or warmness = 1 point, ulcer = 1 point, fissure = 1 point, pustule/abscess = 1 point, suppuration = 1 point, pruritus = 0.5 point, pain = 0.5 point, severe pruritus (≥3 VAS) = 1 point, severe pain (≥3 VAS) = 1 point)
  4. dTaking into consideration the index lesion (hyperkeratosis = 1 point, chronic oedema = 1 point, hypertrophic nail rim = 1 point, deformed toe nail = 1 point, loss of nail = 1 point, scar/deformed toe = 1 point)
  5. eSee the ‘Methods’ section